Showing 4491-4500 of 5771 results for "".
- Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Uphttps://modernod.com/news/will-kids-get-a-covid-19-vaccine-pfizer-to-expand-trial-to-ages-12-and-up/2478411/Pfizer announced Monday that it has received FDA approval to enroll children as young as 12 years old in its COVID-19 vaccine trial. The expansion is aimed at understanding whether the vaccine would be safe and effective for adolescents, according to an NPR
- Santen Joins Forces With Ophthalmologists in the Fight Against Antibiotic Resistancehttps://modernod.com/news/santen-joins-forces-with-ophthalmologists-in-the-fight-against-antibiotic-resistance/2478406/Santen announced the launch of the Re-SOLVE Antibiotic Resistance initiative, which aims to lead the way in the fight against antibiotic resistance in ophthalmology. The initiative will promote and encourage good antibiotic stewardship—a set of actions for the sustainable and effective use of ant
- AstraZeneca to Test Long-Acting Antibody Treatment AZD7442 in COVID-19 Trialshttps://modernod.com/news/astrazeneca-to-test-long-acting-antibody-treatment-azd7442-in-covid-19-trials/2478403/AstraZeneca announced that it will advance its experimental long-acting antibody (LAAB) combination AZD7442 into two phase 3 clinical trials that are due to begin “in the next weeks.”
- Oxular Receives Rare Paediatric Disease and Orphan-Drug Designations for Retinoblastoma Treatmenthttps://modernod.com/news/oxular-receives-rare-paediatric-disease-and-orphan-drug-designations-for-retinoblastoma-treatment/2478404/Oxular Limited announces it has received both rare paediatric disease and orphan drug designations from the FDA for OXU-003, the company’s proprietary drug in development for the treatment of retinoblastoma. Retinoblastoma is a rare form of eye cancer that usually develops in early childho
- Bausch Health Licenses Eyenovia’s Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12https://modernod.com/news/bausch-health-licenses-eyenovias-investigational-treatment-for-the-reduction-of-pediatric-myopia-progression-in-children-ages-3-12/2478405/Bausch Health Companies and Eyenovia announced that an affiliate of Bausch Health has acquired an exclusive license in the United States and Canada for the development and commercialization of an investigational microdose formulati
- EyeCare4Kids Partners with 1-800 Contacts to Launch Sight the Worldhttps://modernod.com/news/eyecare4kids-partners-with-1-800-contacts-to-launch-sight-the-world/2478400/1-800 Contacts and nonprofit EyeCare4Kids announced the launch of Sight the World, which will utilize innovative vision care technology from 1-800 Contacts to provide free glasses and contact lenses for underserved adults and children globally. The announcement comes on World Sight Day, an intern
- AIVITA Biomedical’s Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Sciencehttps://modernod.com/news/aivita-biomedicals-stem-cell-therapeutic-in-vision-loss-published-in-investigative-ophthalmology-vision-science/2478398/AIVITA Biomedical announced the publication of the peer-reviewed manuscript, “Retina organoid transplants develop photoreceptors and improve visual function in RCS rats with RPE dysfunction,” in the journal Investigative Ophthalmology & Visual Science. The
- Orbis International Releases First Guide for Creating Simulation Training Programs for Eye Care Professionalshttps://modernod.com/news/orbis-international-releases-first-guide-for-creating-simulation-training-programs-for-eye-care-professionals/2478395/On World Sight Day, Orbis International announced the release of its Simulation Center Manual, a new practical implementation guide for training hospitals and teaching institutions looki
- Oertli Releases Two Trocar Based Chandelier Solutionshttps://modernod.com/news/oertli-releases-two-trocar-based-chandelier-solutions/2478389/Oertli announced the release of two trocar based chandelier solutions. Using chandelier illumination provides a true bimanual manipulation during vitreoretinal surgery and also one-step access for an easy and quick connection. Chandelier illumination is beneficial for improving intraocular
- Equinox Ophthalmic Appoints Stuart Raetzman as Executive Chairhttps://modernod.com/news/equinox-ophthalmic-appoints-stuart-raetzman-as-executive-chair/2478384/Equinox Ophthalmic announced the appointment of Stuart Raetzman as Executive Chairman. Company founder, John Berdahl, MD, will continue to serve on the Board of Directors and as Chief Medical Officer. Equinox Ophthalmic is a company focused on addressing the unmet need in glau